https://nl.marketscreener.com/koers/aandeel/TIZIANA-LIFE-SCIENCES-LTD-128528512/nieuws/Tiziana-Life-Sciences-Ltd-Doseert-eerste-patient-in-Fase-2A-studie-met-intranasaal-foralumab-bij-m-45599560/?utm_source=telegram&utm_medium=social&utm_campaign=share